Xiao-I Corporation Faces Class Action Lawsuit in New York
Investors in Xiao-I Corporation should be aware that a federal securities class action lawsuit has recently emerged, compelling the attention of those involved. The United States District Court for the Southern District of New York is now overseeing this case, aimed at those who acquired Xiao-I Corporation during its initial public offering (IPO) and the subsequent trading period.
Understanding the Lawsuit Against Xiao-I Corporation
This lawsuit is significant as it raises questions about the company's performance and disclosures following its IPO. Specifically, individuals who purchased American depository shares (ADSs) during the IPO on or around March 9, 2023, and those who traded the stock up to July 12, 2024, are potentially affected.
Details of the Class Period
The class period encompasses securities transactions between March 9, 2023, and July 12, 2024. The intent is to ensure that all investors who acquired shares during this time and incurred losses have a chance to seek redress. If you fit this description, reaching out for more information is crucial.
Key Events Impacting Xiao-I's Stock Performance
Upon its IPO, Xiao-I issued 5.7 million ADSs priced at $6.80 each, drawing in a total capital of approximately $38.76 million. However, following the IPO, the company faced significant challenges. A pivotal moment occurred on September 25, 2023, when Xiao-I reported a staggering net loss of $18.8 million for the first half of the year. This disclosure revealed an alarming increase in total operating expenses by 355% and research and development (R&D) expenses skyrocketing by 708% year-over-year.
Stock Reactions and Investor Losses
The fallout from this news was immediate. Xiao-I's ADS price dropped by $2.70, representing a decline of 14.22%, finishing at $16.29 on that day. As the situation continued to unfold, another financial report on April 30, 2024, disclosed a revenue figure of $59.2 million for the fiscal year 2023 while also reporting a net loss of $27 million. This was compounded by a rise in R&D expenditures of 118.3% compared to the previous year.
These continuous adverse reports resulted in Xiao-I's ADS price declining again, falling by $0.72 to close at $10.98 on April 30, 2024. The negative trend did not stop there; on July 15, 2024, the company reported a notification from NASDAQ regarding non-compliance with minimum bid price requirements, prompting further stock price deterioration.
The Role of Investors in This Class Action
Investors should act swiftly to protect their rights. The deadline to apply as a lead plaintiff in this case is set for December 16, 2024. It is advisable for anyone who has suffered losses to seek assistance from legal representatives familiar with securities class actions.
Contact Information for Investors
Wolf Haldenstein Adler Freeman & Herz LLP is the firm representing the interests of the investors in this case. They possess considerable experience in prosecuting class actions and can provide crucial information on what steps to take next. Those interested can contact the firm directly via email or phone to discuss their situations and comprehend their rights better.
Frequently Asked Questions
What is the basis of the class action lawsuit against Xiao-I Corporation?
The lawsuit is based on claims that Xiao-I Corporation may have misled investors regarding its financial performance, leading to significant losses.
Who is eligible to join the class action lawsuit?
Investors who purchased ADSs during the initial public offering or those who traded the stock during the specified class period are eligible to join the lawsuit.
What steps should investors take if they have incurred losses?
Investors are encouraged to contact the law firm representing the class action to discuss potential participation and know their rights.
What is the deadline to join the class action?
The deadline to apply as a lead plaintiff in this case is December 16, 2024.
How can I learn more about the case?
Investors can contact Wolf Haldenstein Adler Freeman & Herz LLP for further details and guidance on the class action lawsuit.
